drugset / Trial / NCT00002620

Radiation Therapy in Treating Patients With Brain Cancer

NCT00002620

RandomizedTreatment

Summary

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells and may be an effective treatment for patients with anaplastic astrocytomas. PURPOSE: Randomized phase III trial to study the effectiveness of radiation therapy in treating patients with anaplastic astrocytomas.

Timeline

Start
1994-11
Primary completion
2000-06
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject carmustine Small molecule 150 mg/m2
Subject mitolactol Small molecule 1000 mg/m2

Indications